S100A9 promotes inflammasome-dependent autoinflammation by blocking the degradation of SYK tyrosine kinase
Journal of Leukocyte Biology · 2025
DOI: 10.1093/jleuko/qiaf129 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Leukocyte Biology, 2025. Verfasst von Jonas Wolf und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Immunology, University of Münster, Röntgenstr. 21, 48149 Münster, Germany. Hauptthemen laut MEDLINE: Syk Kinase, Inflammasomes, Calgranulin B, Inflammation. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Medizinerkolleg Muenster, Medical Faculty University of Muenster, Bundesministerium für Bildung und Forschung.
Abstract (Originalsprache)
Autoinflammatory diseases such as cryopyrin-associated periodic fever syndrome and familial Mediterranean fever involve an aberrant secretion of interleukin-1β due to genetic defects in the NLRP3 (NOD-, LRR-, and pyrin domain-containing protein 3) or pyrin inflammasomes. The regulatory mechanisms and possible interactions between inflammasome pathways remain unclear. In addition, these conditions show a high expression of the inflammatory alarmins S100A8/A9. Spleen tyrosine kinase is a known regulator of NLRP3 activity, but its connection to S100 proteins and pyrin-driven inflammation has not been described so far. This study demonstrates that S100A9 controls inflammasome activation via spleen tyrosine kinase expression in monocytes. Loss of S100A9 leads to decreased USP10 deubiquitinase expression, resulting in increased autophagosomal degradation of spleen tyrosine kinase. This impairs the S100A9-USP10-SYK pathway inhibiting NLRP3 inflammasome activation and reducing secretion of proinflammatory cytokines and S100A9. Strikingly, blocking this pathway in familial Mediterranean fever monocytes unraveled a so far unknown link between pyrin and NLRP3-driven autoinflammation. These findings identify intracellular S100A9 as a direct regulator of NLRP3 activity and a driver of autoinflammatory responses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Immunology, University of Münster, Röntgenstr. 21, 48149 Münster, Germany.
- Department of Dermatology and Venerology, University Hospital Münster, University of Münster, Von-Esmarch-Str. 58, 48149 Münster, Germany.
- Institute of Immunology, Department of Innate Immunity, University of Tübingen, Auf der Morgenstelle 15, 72076 Tübingen, Germany.
- Pediatric Rheumatology and Autoinflammation Reference Center, Department of Pediatrics I, University Hospital Tübingen, Hoppe-Seyler-Str. 1, 72076 Tübingen, Germany.
- Institute of Biology, University of Hohenheim, Garbenstr. 30, 70599 Stuttgart, Germany.
- CMFI - Cluster of Excellence (EXC 2124), "Controlling Microbes to Fight Infections",University of Tübingen, 72076 Tübingen, Germany.
Förderung
- Medizinerkolleg Muenster
- Medical Faculty University of Muenster
- Bundesministerium für Bildung und Forschung
- ERARE2 projects Treat AID
- Cure AID
- University of Muenster
- DFG
- Volkswagen Stiftung Momentum Program "InnatelyHuman"
Zitieren
APA
Wolf, J., Kusche, Y., Eroglu, F. K., Kümmerle-Deschner, J., Vogl, T., Fritz, G., Weber, A. N. R., Jorch, S. K., Roth, J., & Austermann, J. (2025). S100A9 promotes inflammasome-dependent autoinflammation by blocking the degradation of SYK tyrosine kinase. Journal of Leukocyte Biology. https://doi.org/10.1093/jleuko/qiaf129
Vancouver
Wolf J, Kusche Y, Eroglu FK, Kümmerle-Deschner J, Vogl T, Fritz G, et al. S100A9 promotes inflammasome-dependent autoinflammation by blocking the degradation of SYK tyrosine kinase. Journal of Leukocyte Biology. 2025. doi:10.1093/jleuko/qiaf129
BibTeX
@article{Wolf2025,
author = {Wolf, Jonas and Kusche, Yvonne and Eroglu, Fehime K and Kümmerle-Deschner, Jasmin and Vogl, Thomas and Fritz, Günter and Weber, Alexander N R and Jorch, Selina K and Roth, Johannes and Austermann, Judith},
title = {S100A9 promotes inflammasome-dependent autoinflammation by blocking the degradation of SYK tyrosine kinase},
journal = {Journal of Leukocyte Biology},
year = {2025},
doi = {10.1093/jleuko/qiaf129}
}
EUVIMED